Back to McKinsey Chart of the Day

Between seven and nine COVID-19 vaccines could be approved in the next two years

The world could get seven to nine vaccines over the next two years given historical vaccine success rates and the current pipeline of candidates. The outlook is even more optimistic if the full pipeline of candidates advances toward clinical trials—tripling the likely number of successful vaccines.

Two factors can help reveal vaccines’ potential for success.
We strive to provide individuals with disabilities equal access to our website. If you would like information about this content we will be happy to work with you. Please email us at: McKinsey_Website_Accessibility@mckinsey.com

To read the article, see “On pins and needles: Will COVID-19 vaccines ‘save the world’?,” July 29, 2020.